Literature DB >> 11455475

Primary sclerosing cholangitis successfully treated by resection of the confluence of the hepatic duct.

I Hirai1, S Ishiyama, A Fuse, H Kuzu, F Sakurai, S Kimura, W Kimura.   

Abstract

Primary sclerosing cholangitis (PSC) is a cholestatic disease characterized by chronic inflammatory fibrosis of the extra- and intrahepatic bile ducts. Although the prognosis of patients with PSC was believed to be poor, some patients have not experienced the expected rapid clinical progression. A 51-year-old man with PSC was initially hospitalized for jaundice. Laboratory data showed low levels of the complement components C3, C4, and CH50. Percutaneous transhepatic biliary drainage was performed. Cholangiography revealed complete obstruction of the common bile duct below the confluence of the cystic duct. The confluence of the hepatic duct was resected and it was reconstructed by hepaticojejunostomy for palliation of the obstructive jaundice. Increased thickness of the walls of the common bile duct, right hepatic bile duct, and gallbladder was observed. Histopathological examination of the resected specimen revealed periductal fibrosis, with an onion-skin-like appearance. The patient is currently doing well, approximately 7 years after the surgery, without any signs of PSC recurrence. In this extraordinary patient, the laboratory data for C3, C4, and CH50 showed a complete return to normal levels. The positive results in this patient suggest that resection of the confluence of the hepatic duct may be an effective surgical treatment for noncirrhotic PSC patients who have dominant extrahepatic strictures.

Entities:  

Mesh:

Year:  2001        PMID: 11455475     DOI: 10.1007/s005340170042

Source DB:  PubMed          Journal:  J Hepatobiliary Pancreat Surg        ISSN: 0944-1166


  7 in total

Review 1.  Analytical review of diagnosis and treatment strategies for dominant bile duct strictures in patients with primary sclerosing cholangitis.

Authors:  Murad Aljiffry; Paul D Renfrew; Mark J Walsh; Marie Laryea; Michele Molinari
Journal:  HPB (Oxford)       Date:  2011-02       Impact factor: 3.647

2.  Re-examination of sinusoidal deposition of complement 4d in liver allografts: experience from a single institution.

Authors:  Mohannad Dugum; Medhat Askar; Rish K Pai; Lisa Yerian; Ana Bennett; James McMahon; Hao Xie; Bijan Eghtesad; Ibrahim Hanouneh; Xiuli Liu
Journal:  Int J Clin Exp Pathol       Date:  2014-01-15

Review 3.  Endoscopic and surgical management of primary sclerosing cholangitis.

Authors:  Anthony Michaels; Cynthia Levy
Journal:  Medscape J Med       Date:  2008-10-21

4.  Multidisciplinary approach to benign biliary strictures.

Authors:  Guido Costamagna; Pietro Familiari; Andrea Tringali; Massimiliano Mutignani
Journal:  Curr Treat Options Gastroenterol       Date:  2007-04

5.  Indications for non-transplant surgery in primary sclerosing cholangitis.

Authors:  Bastian Domajnko; Steven A Ahrendt
Journal:  HPB (Oxford)       Date:  2005       Impact factor: 3.647

6.  Common bile duct obstruction palliated with common bile duct re-implantation (choledochoduodenostomy) in a cat.

Authors:  Galina Hayes; Sacha Devereux; John P Loftus; Mason Jager; Gerald Duhamel; Tracy Stokol
Journal:  Can Vet J       Date:  2019-10       Impact factor: 1.008

7.  Complement Inhibition Alleviates Cholestatic Liver Injury Through Mediating Macrophage Infiltration and Function in Mice.

Authors:  Zhenya Guo; Junze Chen; Yonglian Zeng; Zefeng Wang; Mei Yao; Stephen Tomlinson; Bin Chen; Guandou Yuan; Songqing He
Journal:  Front Immunol       Date:  2022-01-07       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.